---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039111"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:41:46.870204+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics presents at Injectables Summit with Enable on SER-252 for Parkinson's

## Summary
- Serina's CDO Randall Moreadith presents at 14th Annual Injectables Summit in Boston on October 2, 2024.
- Joint presentation with Enable Injections' CCO Matthew Huddleston focuses on SER-252 for advanced Parkinson's disease.
- Partnership combines Serina's SER-252 with Enable's enFuse wearable drug delivery platform.
- No financial results, guidance, or other material corporate updates were provided.

## SEC filing metadata
- accession: 0001493152-24-039111
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224039111/0001493152-24-039111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224039111/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039111
- JSON: https://secwatch.observer/filing/0001493152-24-039111.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.